<?xml version="1.0"?>

<document>
	<title>Screening for cystic fibrosis with chloride electrode.  An
   investigation of sweat chloride with chloride electrode orion 417 in
   normal persons and in patients with cystic fibrosis.</title>

	<author>Steinrud-J.</author>
	<author>Winkel-S.</author>
	<author>Flensborg-E-W.</author>

	<source>Dan-Med-Bull. 1974 Oct. 21(6). P 251-5.</source>

	<abstract>An investigation of sweat chloride with chloride electrode Orion 417
   in normal persons and in patients with cystic fibrosis.  Sweat
   chloride values examined with Orion 417 direct-reading skin
   electrode were collected in a group of 811 normal persons and a
   group of 91 patients with cystic fibrosis and were evaluated for
   differences attributable to age and sex.  In the normal group no
   significant difference was found between the two sexes.  In the
   normal group the values among newborns are found to be considerably
   higher than in the rest of childhood.  During the first month of
   life the values decrease to a steady level, which is maintained from
   the age of 1 month to 15 years.  After the age of 15 a steady
   increase takes place.  With data gathered from the normal group we
   propose the following upper limits of &quot;normal&quot; for the sweat
   chloride test: 1 month - 15 years: Chloride 40 meq/l.  16 - 25
   years: Chloride 55 meq/l.  Upon examination of the Cystic Fibrosis
   group, the sweat chloride values in all age groups were found to be
   above the upper limits of normal.  The method is found valuable for
   large scale screening purposes for Cystic Fibrosis.</abstract>

	<majorsubject>CHLORIDES: an</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: me</majorsubject>
	<majorsubject>SWEAT: an</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>ELECTRIC-STIMULATION</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>INFANT</minorsubject>
	<minorsubject>IONTOPHORESIS: is</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>MASS-SCREENING</minorsubject>

	<reference>001   ANDERSON CM           ARCH DIS CHILD                  35   581 960</reference>
	<reference>002   DOERSHUK CF           J PEDIATR                       65   677 964</reference>
	<reference>003   FLENSBORG EW          PROC EWGCF 1ST ANNU MTG                  970</reference>
	<reference>004   GIBSON LE             PEDIATRICS                      23   545 959</reference>
	<reference>005   GRONBAEK P            UGESKR LAEGER                  122  1109 960</reference>
	<reference>006   HANSEN L              AM J CLIN PATHOL                49   834 968</reference>
	<reference>007   KOPITO L              PEDIATRICS                      43   794 969</reference>
	<reference>008   KULCZYCKI LL          AM J DIS CHILD                 100   174 960</reference>
	<reference>009   NIELSEN EL            UGESKR LAEGER                  133  1017 971</reference>
	<reference>010   SHWACHMAN H           PEDIATRICS                      46   335 970</reference>
	<reference>011   SPROUL A              J PEDIATR                       69   759 966</reference>
	<reference>012   SHWACHMAN H           MOD PROBL PEDIATR               10   158 967</reference>
	<reference>013   STEPHAN U             IN: MANGOS JA                        281 973</reference>

	<citation>1   KOLLBERG H            SCAND J CLIN LAB INVEST         35    17 975</citation>
	<citation>2   WARWICK WJ            CLIN CHEM                       24  2050 978</citation>
	<citation>3   DANES BS              MED HYPOTHESES                   5   289 979</citation>
	<citation>4   NIELSEN OH            J PEDIATR GASTROENTEROL NUTR     1   355 982</citation>
	<citation>5   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982</citation>

</document>
